Correlation Between Fidelity Puritan and Biotechnology Portfolio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fidelity Puritan and Biotechnology Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Puritan and Biotechnology Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity Puritan Fund and Biotechnology Portfolio Biotechnology, you can compare the effects of market volatilities on Fidelity Puritan and Biotechnology Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Puritan with a short position of Biotechnology Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Puritan and Biotechnology Portfolio.

Diversification Opportunities for Fidelity Puritan and Biotechnology Portfolio

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Fidelity and Biotechnology is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Puritan Fund and Biotechnology Portfolio Biotec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Portfolio and Fidelity Puritan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Puritan Fund are associated (or correlated) with Biotechnology Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Portfolio has no effect on the direction of Fidelity Puritan i.e., Fidelity Puritan and Biotechnology Portfolio go up and down completely randomly.

Pair Corralation between Fidelity Puritan and Biotechnology Portfolio

Assuming the 90 days horizon Fidelity Puritan Fund is expected to generate 0.37 times more return on investment than Biotechnology Portfolio. However, Fidelity Puritan Fund is 2.69 times less risky than Biotechnology Portfolio. It trades about 0.13 of its potential returns per unit of risk. Biotechnology Portfolio Biotechnology is currently generating about -0.14 per unit of risk. If you would invest  2,507  in Fidelity Puritan Fund on August 28, 2024 and sell it today you would earn a total of  46.00  from holding Fidelity Puritan Fund or generate 1.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fidelity Puritan Fund  vs.  Biotechnology Portfolio Biotec

 Performance 
       Timeline  
Fidelity Puritan 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity Puritan Fund are ranked lower than 10 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Fidelity Puritan is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotechnology Portfolio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Biotechnology Portfolio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Fidelity Puritan and Biotechnology Portfolio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fidelity Puritan and Biotechnology Portfolio

The main advantage of trading using opposite Fidelity Puritan and Biotechnology Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Puritan position performs unexpectedly, Biotechnology Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will offset losses from the drop in Biotechnology Portfolio's long position.
The idea behind Fidelity Puritan Fund and Biotechnology Portfolio Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance